Ads
related to: eli lilly- Press Releases
Find Press Releases
and News for Lilly.
- Lilly Recognitions
Leaders in D&I, R&D, and
Social Impact & Employee Benefits
- About Lilly
Find How Lilly's Purpose Has Never
Been More Important.
- Our Impact
Learn About How We Responsibly
Grow Our Business.
- Press Releases
Search results
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
Business Insider via Yahoo Finance· 2 days agoZepbound is Eli Lilly's new weight-loss drug.Brendan McDermid/Reuters The anti-obesity drug market...
Watch Out Wegovy: Here Comes Another Promising Anti-Obesity Candidate | The Motley Fool
The Motley Fool· 16 hours agoInvestors interested in the pharmaceutical industry are currently excited about the anti-obesity...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 1 day agoBuying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a...
Is Eli Lilly And Co (NYSE:LLY) the Best Weight Loss Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 4 days agoWe recently published a list of Jim Cramer’s Top 10 Stock Picks for June. Since Eli Lilly And Co...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
Business Insider· 2 days agoThe anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a...
Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In Spotlight
Investor's Business Daily· 10 hours agoTop drugmakers Eli Lilly and Novo Nordisk also make this list of top growth stocks. Eli Lilly now...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors | The Motley Fool
The Motley Fool· 3 days agoEli Lilly (LLY 0.65%) and Novo Nordisk (NVO 1.87%) are the two most valuable healthcare companies in...
The Zacks Analyst Blog Highlights Eli Lilly, T-Mobile US, BHP, American International and Exelon
Zacks· 1 day agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli
Lilly gilds neuro pipeline, paying QurAlis $45M for preclinical ALS, dementia prospect
FierceBiotech· 21 hours agoEli Lilly is splicing another asset onto its neurodegenerative disease pipeline, paying QurAlis $45 million for rights to a preclinical treatment for amyotrophic ...
Lilly seeks to build conference center on downtown HQ campus - Indianapolis Business Journal
Indianapolis Business Journal· 4 days agoEli Lilly and Co. plans to build a 57,000-square-foot conference center on an existing parking lot...
Ad
related to: eli lilly